Chief Scientific Officer at Children’s Hospital Los Angeles Appointed to CIRM Board
April 9, 2021
Pat Levitt, PhD, joins governing board of California’s stem cell agency
Content related to Children’s Hospital Los Angeles Chief Scientific Officer Named to California Stem Cell Research Body Governing Board
Pat Levitt, PhD, Named Inaugural Chief Scientific Officer at Children's Hospital Los Angeles
May 24, 2018
Pat Levitt, PhD, has been named Vice President, Chief Scientific Officer and Director of The Saban Research Institute of Children’s Hospital Los Angeles.
Children’s Hospital Los Angeles Welcomes Members Added to the CHLA Board of Directors in 2020
November 18, 2020
Children’s Hospital Los Angeles is pleased to announce the election of four new independent members—Diana M. Bontá, RN, DrPH; George H. Brown; Byron Pollitt; and Sheri Sani, CPA—and the appointment of
Critical Windows When Experience Shapes the Brain
May 16, 2019
Pat Levitt, PhD, Chief Scientific Officer at Children’s Hospital Los Angeles and Simms/Mann Chair in Developmental Neurogenetics, received a $3.7M grant from the National Institute of Mental Health to
Dr. Paul F. Kantor Named New Cardiology Chief and Heart Institute Co-Director at Children’s Hospital Los Angeles
February 4, 2019
LOS ANGELES — After an extensive search across North America, Children’s Hospital Los Angeles (CHLA) has appointed Paul F. Kantor, MBBCh, MSc, FRCPC, as the new chief of the Division of Cardiology and
Method Developed by Children’s Hospital Los Angeles Researchers Automates Brain Cell Mapping
December 15, 2022
Open-source technique streamlines cell identification and analysis.
California’s Stem Cell Agency Awards CHLA $5 Million Training Grant
November 2, 2021
Stem cells are the seeds that grow our hearts, brains, lungs, intestines—every one of the body’s tissues and organs. By studying stem cells and their potential to replace damaged or dysfunctional
Wired for Obesity
January 23, 2019
Leading a unique, collaborative research study with scientists across the globe, investigators at the University of Cambridge and Children’s Hospital Los Angeles have pinpointed a set of molecules